Legacy MEDSearch

SEPTEMBER 18, 2023

Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of the study of the eShunt System in patients with Normal Pressure Hydrocephalus (NPH) to additional study participants and clinical sites. . Located in Massachusetts’ healthcare hub, CereVasc, Inc.,

Food and Drug Administration 52

Food and Drug Administration FDA Patients Recruitment 52

Legacy MEDSearch

AUGUST 23, 2023

Food and Drug Administration (FDA) Circulatory Systems Devices Panel of the Medical Devices Advisory Committee met to discuss the pre-market approval application (PMA) for the Paradise Ultrasound Renal Denervation (RDN) system, indicated to reduce blood pressure in patients with hypertension. Otsuka Medical Devices”) announce the U.S.

Medical 52

Medical Food and Drug Administration FDA Recruitment 52

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

Pharmaceutical Technology

DECEMBER 5, 2022

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has also since granted the Great Britain marketing authorisation of Lupkynis to treat adults with active LN. Notably, Lupkynis is the first oral therapy approved by the US Food and Drug Administration (FDA) and EC for the treatment of active LN.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59

European Pharmaceutical Review

MARCH 4, 2024

Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 The emergency use approval from the FDA of lipid nanoparticle- (LNP-) based mRNA vaccines during the COVID-19 pandemic attested the significance of LNPs.

Food and Drug Administration 87

Food and Drug Administration Transportation FDA Medical 87

pharmaphorum

DECEMBER 14, 2022

Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In 2020, the FDA-approved indication was expanded to include those patients who suffer from cataplexy. Monopoly money.

Competition 85

Competition FDA Pharmaceutical Marketing 85

Pharmaceutical Technology

MARCH 24, 2023

Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. In addition, two more Humira biosimilars are currently under FDA review and both are anticipated to launch in 2023.

Competition 59

Competition Marketing FDA Physicians 59

PM360

DECEMBER 14, 2023

“We’re now leveraging our expertise in communicating with healthcare professionals to deliver essential information and practical tools to physicians and other healthcare providers to help them address the challenges faced by patients with chronic illness.”

Physicians 52

Physicians Pharma Medical Patients 52

Pharma Marketing Network

OCTOBER 11, 2021

Panelists, from clinicians to marketing executives, discussed the current leap in digital healthcare, along with what the future holds for this rapidly evolving segment. For example, physicians working with patients in other geographies will need to familiarize themselves with the resources available in the patient’s location.

Healthcare 59

Healthcare Healthcare Marketing Insurance 59

Pharma Marketing Network

OCTOBER 11, 2021

Panelists, from clinicians to marketing executives, discussed the current leap in digital healthcare, along with what the future holds for this rapidly evolving segment. For example, physicians working with patients in other geographies will need to familiarize themselves with the resources available in the patient’s location.

Healthcare 52

Healthcare Healthcare Marketing Insurance 52

LEVO Health

OCTOBER 26, 2022

Food & Drug Administration (FDA) classifies medical devices. They have regulatory controls and marketing pathways you have to follow based on the risk of your device and its overall safety and effectiveness. How the FDA Classifies Medical Devices. They are not obligated to submit data or information to the FDA. .

Medical 52

Medical Marketing Patients Food and Drug Administration 52

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. But one key member is often omitted: the patient’s caregiver.

Pharma 98

Pharma Education Transportation Training 98

pharmaphorum

AUGUST 11, 2022

The industry is reaching a tipping point where technologies are coming closer to delivering on its strong promises in improved healthcare for countless patients, helping to dramatically decrease costs across the board. The current healthcare system, unfortunately, sees pharmacogenomics testing as a reactive strategy.

Side effects 78

Side effects Medical Prescription Patients 78

European Pharmaceutical Review

NOVEMBER 8, 2022

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. Citizen Petitions before the FDA. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

PM360

AUGUST 9, 2022

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. Furthermore, it is estimated to reach $6.5 Andrew Mills.

Prescription 105

Prescription Medical Side effects Patients 105

European Pharmaceutical Review

JULY 13, 2023

In many European countries physicians can now prescribe medical cannabis for an array of chronic health conditions, including chronic pain, mental health disorders and neurological conditions. It is estimated that only one in 10 drugs that enter Phase I trials are subsequently licensed by the US Food and Drug Administration (FDA).

Medical 83

Medical Food and Drug Administration Pharmacology Medicine 83

pharmaphorum

SEPTEMBER 16, 2022

The week 16 data of lebrikizumab […] points towards a drug with robust efficacy with hardly any safety trade-offs. The FDA granted lebrikizumab Fast Track designation in December 2019. He explained just how promising the recent trial’s maintenance data compared to short-term data results are. Thyssen, MD, Ph.D.

Management 69

Management Side effects Patients Safety 69

Legacy MEDSearch

OCTOBER 25, 2023

Theranica , a neuromodulation therapeutics company, announced the publication of a comprehensive clinical study in Advances in Therapy examining the long-term utilization, clinical efficacy, and safety of Nerivio ® , a Remote Electrical Neuromodulation (REN) device for the treatment of migraine.

Side effects 52

Side effects Recruitment Networking Management 52

Clarivate

OCTOBER 10, 2022

Based on the TROPICS-02 trial results, Gilead has submitted a supplemental biologics license application (sBLA) to the FDA, seeking a label expansion for TRODELVY in the much larger setting of metastatic HR+/HER2-negative breast cancer. Key ESMO findings. months; HR: 0.321, P<0.001). months; HR: 0.321, P<0.001). Market impact.

Marketing 52

Marketing Safety Patients Competition 52

Pharma Marketing Network

APRIL 1, 2023

They understand the unique challenges faced by medical device companies, such as navigating the complex regulatory landscape and reaching healthcare professionals and patients. Please always check and confirm with your own sources, and always consult with your healthcare professional when seeking medical treatment.

Pharma 52

Pharma Medical Pharmaceutical Marketing 52

Clarivate

MAY 24, 2022

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Gain access to intelligence on Mainland China’s healthcare market and disease-specific trends. 10] [11] [12].

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. They narrowed the eligibility criteria, much beyond what was approved by the FDA.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

pharmaphorum

JULY 6, 2022

Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. Now, in addition to doctors and providers, the FDA announced pharmacists with your medical information can prescribe Paxlovid to patients. It made $1.5

FDA 92

FDA Doctors Side effects Patients 92

pharmaphorum

OCTOBER 26, 2022

There are many challenges in the development of therapies for rare diseases due to several unique factors, including small target patient populations, lack of long-term safety and efficacy data or natural history data, and often complex administration, dosing, and patient monitoring requirements,” Chiesi says. Chiesi’s philosophy in action.

Patients 69

Patients Pharma Consulting Transportation 69

pharmaphorum

SEPTEMBER 12, 2022

Through partnerships and internal innovation, LabCorp is utilising these advances in order to improve healthcare stakeholders’ experiences for better patient results. This reach allows us to support 82% of the novel drugs and therapeutic products approved by the US FDA, including 63% of those specific to oncology,” Reddy states.

Patients 93

Patients Medicine FDA Healthcare 93

European Pharmaceutical Review

SEPTEMBER 21, 2023

Considerable progress has been made in other areas including enhancing safety, improving treatment administration and patient monitoring systems and implementing innovative pricing strategies – all with the goal of providing timely access to eligible patients who can benefit from these treatments. Internet] FDA. Annu Rev Med.

Pharmaceutical 73

Pharmaceutical Food and Drug Administration Medicine Manufacturing 73

Pharmaceutical Technology

JANUARY 16, 2023

“With the approval of the Tezspire pre-filled pen, we can give patients in Europe greater flexibility and support physicians in treating a broad population of severe asthma patients.”. Throughout the PATH-HOME trial, 92% of the patients, healthcare providers, and caregivers could successfully administer Tezspire in the clinic and at home.

Food and Drug Administration 59

Food and Drug Administration Healthcare Provider Medicine Physicians 59

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. Amazon Goes DTC. The services are cash pay only at this point. Pfizer’s Giant Ireland Investment.

Manufacturing 52

Manufacturing Medical Healthcare Healthcare 52

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. There’s no dearth of interest, however, in applying digital solutions to healthcare.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

Clarivate

OCTOBER 7, 2021

As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks. Context: In August 2021, Merck & Co.

Patients 91

Patients Safety Marketing Physicians 91

Legacy MEDSearch

MAY 1, 2023

the developer of a transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced results from the OASIS pivotal trial evaluating the safety and efficacy of the BlueWind System in the treatment of OAB. Results from the trial are under review by the FDA. BlueWind Medical, Ltd.,

Patients 52

Patients Medical Safety Recruitment 52

Legacy MEDSearch

SEPTEMBER 27, 2023

Its flagship product, the Personal Cardiac Assistant (PCA 500) , is the only hospital-grade, resting 12-lead ECG device cleared by the FDA and CE marked for both professional and patient use. QT Medical aims to provide improved cardiac devices and services to revolutionize the care of patients with heart disease.

Medical 52

Medical Recruitment Leads Management 52

Medgadget

MARCH 2, 2023

Moreover, due to the different nature of healthy and cancerous tissue, alpha radiation produced by Alpha DaRT sources diffuses about a millimeter into healthy tissue while penetrating at a diameter up to about five millimeters into tumors, providing an automatic safety mechanism. The rest of the patients had partial responses.

Manufacturing 83

Manufacturing Leads Patients Medicine 83

Nixon Gwilt Law

NOVEMBER 5, 2021

Overview The Centers for Medicare and Medicaid Services (CMS) issued its Omnibus COVID-19 Health Care Staff Vaccination Interim Final Rule (IFR) on November 4, 2021, the same day the Department of Labor’s Occupational Safety and Health Administration (OSHA) issued its COVID-19 Vaccination and Testing Emergency Temporary Standard (ETS).

Healthcare 52

Healthcare Healthcare Training Safety 52